The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Pennsylvania Hospital, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Neoplasms; Anilides; Pyridines; Antineoplastic Agents; Mutation; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
41066729
PubMed Central ID
PMC13488493
Added to directory
Source checked

Report a correction or request removal